Issue 182

29.01.2021

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

HIGHLIGHTS 

FRANCE ANNOUNCES SELECTION OF INTERNATIONAL SUPPLIERS FOR MEDICAL CANNABIS TRIAL

 

 

Following an extensive public consultation phase, the French government has announced the names of the companies which will supply medical cannabis for use in a trial involving thousands of volunteers.

The programme will support patients suffering from epilepsy, pain, the side- effects of chemotherapy and multiple sclerosis and will only be available to those who have reached a ‘treatment impasse’.

READ MORE

 


 

HIGHLIGHTS

 

ISRAELI CANNABIS FIRM SET TO LIST ON NASDAQ EXCHANGE

SCOTTISH MP CAMPAIGNS FOR BETTER ACCESS TO MEDICAL CANNABIS

 

Europe

PROHIBITION PARTNERS WEBINAR SERIES

CONNECT WITH LEADING FIGURES OPERATING IN THE NORTH AMERICAN CANNABIS  MARKET

 

 

In what is an exciting time for the future of Cannabis in the USA, the latest Prohibition Partners report takes a laser focus to a crucial part of the global industry map.

This online launch event takes a look forward with the recent changes in the North American cannabis industry; across potential federal reform, ground-breaking social equity programmes and future market growth.

 

REGISTER FOR FREE NOW

USA

REPORT

SURVEY OF GERMAN CANNABIS CONSUMERS REVEALS DYNAMIC RANGE OF USE

 

 

Despite the fact that millions of Germans are using CBD and cannabis, relatively little is currently known about these consumers.

In this report, we highlight the topics which are most pressing for patients and consumers and should be of significant value to anyone wishing to meet the growing demand for these products in the country.

 

READ MORE

CANADA

LATAM & CARIBBEAN

APAC

AFRICA & MIDDLE EAST

 

Read the stories that shape the cannabis industry